Zhou Li-Fang, Zhang Mao-Xin, Kong Ling-Qian, Lyman Gary H, Wang Ke, Lu Wei, Feng Qi-Ming, Wei Bo, Zhao Lue Ping
a Information and Management School , Guangxi Medical University , Nanning , China.
b Fourth Affiliated Hospital of Guangxi Medical University , Liuzhou , China.
Cancer Invest. 2017 May 28;35(5):345-357. doi: 10.1080/07357907.2017.1296156. Epub 2017 Apr 3.
Lung cancer is a common disease with high mortality in China. Recent economic advances have led to improved medical capabilities, while costs associated with treating this disease have increased. Such change contributes to a commonly held belief that healthcare costs are out of control. However, few studies have examined this issue. Here, we use 34,678 hospitalization summary reports from 67 Guangxi hospitals (period 2013-2016) to document costs, temporal trends, and associated factors. Findings from this study are surprising in that they debunk the myth of uncontrolled healthcare costs. In addition, results and experiences from Guangxi are informative for other comparable regions.
肺癌在中国是一种常见且死亡率高的疾病。近期的经济发展带来了医疗能力的提升，然而治疗这种疾病的相关费用也有所增加。这种变化使得人们普遍认为医疗费用失控。然而，很少有研究探讨过这个问题。在此，我们使用来自广西67家医院的34678份住院总结报告（时间段为2013 - 2016年）来记录费用、时间趋势及相关因素。这项研究的结果令人惊讶，因为它们揭穿了医疗费用失控的神话。此外，广西的研究结果和经验对其他类似地区具有参考价值。
